Cibc World Market Inc. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 37,460 shares of the company’s stock, valued at approximately $14,605,000.
A number of other institutional investors also recently modified their holdings of the business. OMERS ADMINISTRATION Corp bought a new position in HCA Healthcare in the 2nd quarter worth approximately $4,832,000. Osmosis Investment Management UK Ltd purchased a new stake in shares of HCA Healthcare during the second quarter worth $1,794,000. Sanctuary Advisors LLC purchased a new position in shares of HCA Healthcare in the second quarter valued at $3,814,000. Solstein Capital LLC purchased a new stake in HCA Healthcare during the 2nd quarter worth about $58,000. Finally, Meiji Yasuda Asset Management Co Ltd. bought a new stake in shares of HCA Healthcare during the second quarter valued at about $996,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Stock Performance
Shares of NYSE:HCA opened at $429.19 on Tuesday. The firm has a fifty day moving average of $397.94 and a 200 day moving average of $443.28. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The firm has a market capitalization of $92.92 billion, a PE ratio of 14.37, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10.
HCA Healthcare Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.
Analyst Ratings Changes
HCA has been the subject of a number of analyst reports. Leerink Partners cut their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a report on Tuesday, July 7th. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. The Goldman Sachs Group reduced their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research report on Tuesday, July 28th. Finally, Morgan Stanley dropped their price target on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $462.64.
Get Our Latest Research Report on HCA Healthcare
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
